Tenet Healthcare (THC1) Stock Price & Analysis
THC1 Stock Chart & Stats
- Day’s Range
- EUR 232.00 - EUR 248.00
- 52-Week Range
- EUR 132.00 - EUR 248.00
- Previous Close
- EUR 246.00
- Volume
- N/A
- Average Volume (3M)
- 2
- Market Cap
- EUR 19.44B
- Enterprise Value
- EUR 35.32B
- Total Cash (Recent Filing)
- EUR 2.67B
- Total Debt (Recent Filing)
- EUR 13.24B
- Price to Earnings (P/E)
- 7.7
- Beta
- 0.42
- Next Earnings
- Feb 11, 2027 (Est.)
- EPS Estimate
- 4.78
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Ambulatory Growth And Margins
USPI combines strong profitability with a scalable outpatient model, supporting durable earnings expansion as procedures migrate to ambulatory settings. Its high margins, physician alignment, and continued development and acquisition activity can strengthen Tenet’s competitive position over the next several quarters.
Strong Cash Generation
Robust free cash flow and substantial cash on hand improve Tenet’s ability to fund growth, reduce financial stress, and return capital to shareholders. The absence of revolver borrowings also provides liquidity flexibility if operating conditions or reimbursement trends become less favorable.
Commercial Pricing Visibility
Favorable commercial pricing and high contract coverage provide greater visibility into reimbursement revenue than reliance on spot negotiations would allow. This supports margin planning, helps offset cost inflation, and gives management a more stable foundation for near-term operating execution.
Bears Say
Medicaid And Exchange Exposure
Tenet’s substantial exposure to Medicaid expansion states leaves reimbursement and patient coverage vulnerable to policy changes. Potential work requirements, exchange volume pressure, and uncertainty around supplemental payments could reduce admissions, increase uncompensated care, and pressure revenue growth.
Nonrecurring Conifer Benefit
Recent earnings benefited materially from Conifer transition activities that management identifies as nonrecurring. As that contribution rolls off, reported EBITDA growth will face a tougher comparison, requiring hospital and USPI operations to deliver sufficient underlying improvement to sustain momentum.
Balance-sheet Trend Inconsistency
The dramatic improvement in reported leverage is encouraging but not a steady multi-year trend, making the durability of Tenet’s balance-sheet strength harder to underwrite. Historical leverage was high, so changes in debt or equity could materially affect flexibility and financial risk.
Tenet Healthcare News
THC1 FAQ
What was Tenet Healthcare’s price range in the past 12 months?
What is Tenet Healthcare’s market cap?
When is Tenet Healthcare’s upcoming earnings report date?
How were Tenet Healthcare’s earnings last quarter?
Is Tenet Healthcare overvalued?
Does Tenet Healthcare pay dividends?
What is Tenet Healthcare’s EPS estimate?
How many shares outstanding does Tenet Healthcare have?
What happened to Tenet Healthcare’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Tenet Healthcare?
What is the TipRanks Smart Score and how is it calculated?
Tenet Healthcare Stock Smart Score
Company Description
Tenet Healthcare
Tenet Healthcare Corporation operates as a broad-ranging provider of health solutions. The company organizes its operations across three main divisions: Hospital Operations and Other, Ambulatory Care, and Conifer. Within its network of acute care facilities, Tenet delivers a full spectrum of essential services. These include core hospital functions such as operating and recovery suites, radiology and respiratory therapy, clinical laboratories, and on-site pharmacies. The organization also provides high-acuity patient care through intensive, critical, and coronary care units. Specialized medical services cover areas like cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics, alongside various outpatient treatments, including physical therapy. Advanced surgical capabilities feature cardiothoracic, complex spinal, and neurosurgery, as well as neonatal intensive care. Tenet extends its offerings to ultra-specialized quaternary care, exemplified by heart and kidney transplant programs, and sophisticated procedures such as limb-salvaging vascular interventions, acute Level 1 trauma care, intravascular stroke treatment, minimally invasive cardiac valve replacements, advanced imaging, and telemedicine access. Beyond its hospital network, Tenet manages numerous other clinical sites. These encompass outpatient surgical centers, immediate care facilities, diagnostic imaging centers, dedicated surgical hospitals, off-campus emergency departments, and micro-hospitals. Through its Conifer segment, the company furnishes critical healthcare business process solutions. These administrative services, offered to hospitals, health systems, physician practices, employers, and other clients, include financial administration for patient accounts (revenue cycle management), support for patient communications and engagement, and outcome-focused care strategies. As of February 9, 2022, Tenet's operational footprint included 60 hospitals and roughly 550 additional medical facilities. This count of additional sites comprises surgical hospitals, ambulatory surgery centers, urgent care and imaging centers, and various other clinical locations. Tenet Healthcare Corporation was established in 1975 and maintains its principal office in Dallas, Texas.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Saumya Sutaria
- Employees
- 88,500
- Website
- www.tenethealth.com
- Address
- 14201 Dallas Parkway, Dallas, TX, 75254, US
Tenet Healthcare (THC1) Earnings & Revenues
THC1 Company Deck
THC1 Earnings Call
Earnings Call SentimentPositive
The call was strongly positive overall. Tenet delivered substantial earnings, margin, cash flow, and share-repurchase performance; raised its 2026 revenue, EBITDA, and free cash flow guidance; and expressed confidence in core EBITDA growth for 2027. The principal challenges were exchange-related volume and coverage pressure, lower USPI case volumes, the nonrecurring nature of Conifer transition contributions, and uncertainty surrounding Medicaid work requirements, HR 1, and future regulatory conditions.
View all DE:THC1 earnings summariesTHC1 Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 9 | 5 | 8 |
| Technical Analysis | 4 | 5 | 1 |
| Moving Averages | 5 | 0 | 7 |
